Female Pattern Hair Loss: Beyond an Androgenic Aetiology?

    July 2010 in “ British Journal of Dermatology ”
    Ewan A. Langan, Ralf Paus
    Image of study
    TLDR Estrogen and prolactin may play bigger roles in female hair loss than previously thought.
    The article discusses the potential role of estrogen and prolactin in female pattern hair loss (FPHL), beyond the commonly accepted androgenic cause. The authors suggest that the importance of estrogen in normal female scalp hair follicle function and FPHL pathogenesis may be underestimated and could even exceed that of androgens. They also propose that prolactin may potentially constitute another important mechanism contributing to FPHL in androgen insensitivity syndrome. The authors recommend that future research into FPHL and its treatment should not be restricted to an androgenic etiology.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Testosterone and hair loss seeming irrelevance

      in Research/Science  81 upvotes 1 year ago
      The conversation is about the role of testosterone in hair loss and the effectiveness of different treatments. The conclusion is that DHT is the main culprit for hair loss, and finasteride has been proven to work long-term in maintaining and regrowing hair. Testosterone may have a minor effect, but it is not the primary cause of hair loss.

      community hmi115 is coming. Prepare yourselves for what's coming

      in Technology  106 upvotes 1 year ago
      The conversation discusses HMI-115, a potential cure for hair loss. Users share mixed opinions, with some expressing skepticism and others sharing anecdotal evidence of its effectiveness, including photos of significant hair regrowth from a trial participant.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  123 upvotes 11 months ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

    Related Research

    6 / 6 results